Loading patent…
AssigneeLG Chem, Ltd.
InventorsSeok Cheol YOO, Sung Won KIM, Jung Gyu PARK, Sei Hyun CHOI, Hee Dong PARK, Jae Uk BAEK
Estimating the term…
The present invention relates to an injectable pharmaceutical composition containing a caspase inhibitor, and a preparation method therefor, and, more specifically, to an injectable pharmaceutical composition, and a preparation method therefor, the composition comprising: as an active ingredient, (R)-N-((2S,3S)-2-(fluoromethyl)-2-hydroxy-5-oxotetrahydrofuran-3-yl)-5-isopropyl-3-(isoquinolin-1-yl)-4,5-dihydroisoxazole-5-carboxamide, which is a caspase inhibitor, or a pharmaceutically acceptable salt or isomer thereof; and, as a biocompatible polymer, microspheres containing poly(lactide-co-glycolide).
A pharmaceutical composition for injection comprising a microsphere which comprises (R)-N-((2S,3S)-2-(fluoromethyl)-2-hydroxy-5-oxotetrahydrofuran-3-yl)-5-isopropyl-3-(isoquinolin-1-yl)-4,5-dihydroisoxazole-5-carboxamide, or a pharmaceutically acceptable salt or isomer thereof as an active ingredient;
A method for preparing a pharmaceutical composition for injection comprising:
Dependencies are inferred from the claim text.